Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Total Liabilities (2020 - 2025)

RxSight's Total Liabilities history spans 6 years, with the latest figure at $36.1 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 3.2% year-over-year to $36.1 million; the TTM value through Dec 2025 reached $36.1 million, down 3.2%, while the annual FY2025 figure was $36.1 million, 3.2% down from the prior year.
  • Total Liabilities reached $36.1 million in Q4 2025 per RXST's latest filing, up from $32.6 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $301.9 million in Q1 2021 to a low of $19.2 million in Q1 2024.
  • Average Total Liabilities over 5 years is $54.3 million, with a median of $37.7 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: plummeted 88.16% in 2021, then soared 75.34% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then crashed by 63.18% to $22.2 million in 2023, then soared by 68.22% to $37.3 million in 2024, then decreased by 3.2% to $36.1 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Total Liabilities are $36.1 million (Q4 2025), $32.6 million (Q3 2025), and $31.0 million (Q2 2025).